Po-Lin Lin Selected Research

XAV939

4/2016	DDX3 enhances oncogenic KRAS‑induced tumor invasion in colorectal cancer via the β‑catenin/ZEB1 axis.
2/2016	DDX3 promotes tumor invasion in colorectal cancer via the CK1ε/Dvl2 axis.
1/2016	Cytoplasmic localization of Nrf2 promotes colorectal cancer with more aggressive tumors via upregulation of PSMD4.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Po-Lin Lin Research Topics

Disease

16	Neoplasms (Cancer) 01/2020 - 08/2013
7	Heart Failure 01/2022 - 01/2021
7	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 10/2014
4	Atrial Fibrillation 01/2022 - 01/2019
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020 - 12/2015
3	Thromboembolism 01/2022 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2021
2	Stroke (Strokes) 01/2022 - 01/2021
2	Hypertension (High Blood Pressure) 01/2021 - 03/2019
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 09/2017 - 05/2016
2	Lung Neoplasms (Lung Cancer) 05/2016 - 08/2013
2	Colonic Neoplasms (Colon Cancer) 04/2016 - 02/2016
1	Essential Hypertension 02/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Diabetes Mellitus 01/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 02/2020
1	Overweight 02/2020
1	Weight Loss (Weight Reduction) 02/2020
1	Carcinogenesis 01/2018
1	Hepatocellular Carcinoma (Hepatoma) 01/2018
1	Neoplasm Metastasis (Metastasis) 09/2017
1	Pathologic Constriction (Stenosis) 01/2016
1	Adenocarcinoma of Lung 08/2013
1	Persistent Infection 08/2013

Drug/Important Bio-Agent (IBA)

5	CateninsIBA 05/2018 - 10/2014
5	Messenger RNA (mRNA)IBA 01/2018 - 08/2013
4	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2022 - 01/2021
3	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2021
3	RivaroxabanIBA 01/2022 - 01/2021
3	IvabradineIBA 10/2021 - 01/2021
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2015
3	carfilzomibIBA 01/2020 - 01/2016
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 04/2015
3	XAV939IBA 04/2016 - 01/2016
2	Dronedarone FDA Link 07/2021 - 01/2021
2	Anti-Arrhythmia AgentsIBA 07/2021 - 01/2019
2	Fluorouracil (Carac)FDA LinkGeneric 01/2019 - 05/2018
2	Tyrosine Kinase InhibitorsIBA 01/2018 - 11/2017
2	Oncogene Proteins (Oncogene Protein)IBA 09/2017 - 05/2016
2	TL 1IBA 09/2017 - 05/2016
1	Enalapril FDA LinkGeneric 01/2022
1	Amiodarone (Amiodarona)FDA LinkGeneric 07/2021
1	Propafenone (Rythmol)FDA LinkGeneric 07/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Warfarin (Coumadin)FDA LinkGeneric 01/2021
1	lorcaserinIBA 02/2020
1	PlatinumIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	LigandsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	hepatitis B virus X proteinIBA 01/2018
1	B7-H1 AntigenIBA 11/2017
1	VaccinesIBA 09/2017
1	Cetuximab (Erbitux)FDA Link 01/2017
1	perifosineIBA 04/2016
1	3- (3- chlorophenoxymethyl)- 1- (tetrahydropyran- 4- yl)- 1H- pyrazolo(3,4- d)pyrimidin- 4- ylamineIBA 02/2016
1	Adenosine (Adenocard)FDA LinkGeneric 01/2016
1	MicroRNAs (MicroRNA)IBA 12/2015
1	Serine (L-Serine)FDA Link 04/2015
1	PaxillinIBA 04/2015
1	Interleukin-10 (Interleukin 10)IBA 08/2013

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2021
4	Drug Therapy (Chemotherapy) 01/2020 - 08/2013
2	Denervation 02/2022 - 03/2019
1	Catheter Ablation 01/2022
1	Catheters 03/2019
1	Immunotherapy 09/2017